Stem definition | Drug id | CAS RN |
---|---|---|
5574 | 104054-27-5 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
MeSH PA | D018663 | Adrenergic Agents |
MeSH PA | D058669 | Adrenergic alpha-2 Receptor Antagonists |
MeSH PA | D000317 | Adrenergic alpha-Antagonists |
MeSH PA | D018674 | Adrenergic Antagonists |
MeSH PA | D018377 | Neurotransmitter Agents |
None
Species | Use | Relation |
---|---|---|
Dogs | Reverses the effects of dexmedetomidine hydrochloride | Indication |
Dogs | Reverses the effects of medetomidine hydrochloride | Indication |
Product | Applicant | Ingredients |
---|---|---|
Antisedan | Orion Corp. | 1 |
REVERTIDINE | Modern Veterinary Therapeutics LLC | 1 |
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Alpha-2A adrenergic receptor | GPCR | Ki | 8.73 | CHEMBL | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 8.65 | CHEMBL | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 8.38 | CHEMBL | |||||
Alpha-1B adrenergic receptor | GPCR | Ki | 5.71 | CHEMBL |
ID | Source |
---|---|
CHEMBL353972 | ChEMBL_ID |
C050701 | MESH_SUPPLEMENTAL_RECORD_UI |
12576 | IUPHAR_LIGAND_ID |
104075-48-1 | SECONDARY_CAS_RN |
DB11481 | DRUGBANK_ID |
019299 | NDDF |
019300 | NDDF |
C0052593 | UMLSCUI |
6144 | INN_ID |
125709001 | SNOMEDCT_US |
763010009 | SNOMEDCT_US |
D03002 | KEGG_DRUG |
71310 | PUBCHEM_CID |
18475 | RXNORM |
03N9U5JAF6 | UNII |
None